Today is a landmark day, representing the culmination of a six-year bankruptcy and mediation process,” said Steve Miller, Purdue Board Chairman. “The Plan is the product of intense work with our ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...

A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S. opioid ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...

OxyContin maker Purdue Pharma, blamed for helping to fuel a deadly opioid crisis, said Friday that a US bankruptcy judge will ...

Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge Robert ...

A judge said Friday that he planned to approve a deal for OxyContin maker Purdue Pharma and members of the Sackler family who ...

A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states, tribes, ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription ...